Table 2 Baseline characteristics (median (IQR)) of women with hypertension at follow-up
From: Short term sequelae of preeclampsia: a single center cohort study
No HT (n = 164) | BP ≥140/90 (n = 38) | p-value | No HT (n = 187) | BP ≥ 150/100 (n = 15) | p-value | |
|---|---|---|---|---|---|---|
Age | 32 (28–36) | 34 (30–37) | 0.16 | 32 (28–36) | 32 (29–40) | 0.59 |
Onset (d) | 260 (241–274) | 250 (233–267) | 0.08 | 259 (241–273) | 250 (217–263) | 0.12 |
Early onset | 20.3% (32/158) | 29.7% (11/37) | 0.21 | 21.1% (38/180) | 33.3% (5/15) | 0.27 |
Nulliparous | 75.6% (124/162) | 68% (26/38) | 0.30 | 75.1% (139/185) | 73.3% (11/15) | 0.88 |
Time to f/u (d) | 180 (155–191) | 182 (132–190) | 0.33 | 180 (153–191) | 176 (121–187) | 0.18 |
MP | 14.0% (23/164) | 10.5% (4/38) | 0.57 | 14.4% (27/187) | 0% (0/15) | 0.11 |
IVF | 6.7% (11/164) | 5.7% (2/38) | 0.74 | 7.0% (13/187) | 0% (0/15) | 0.29 |
GD | 7.9% (13/164) | 15.8% (6/38) | 0.13 | 9.1% (17/187) | 13.3% (2/15) | 0.56 |
HELLP | 21.9% (35/160) | 15.8% (6/38) | 0.40 | 21.9% 40/183 | 6.7% (1/15) | 0.16 |
Severe PE | 67.3% (107/159) | 64.1% (25/39) | 0.86 | 67.0% (122/182) | 66.7% (10/15) | 0.97 |
AKI | 9.7% (14/145) | 5.3% (3/38) | 0.86 | 7.7% (14/182) | 20.0% 3/15 | 0.10 |